NR565 Week 5 DM & Thyroid Meds NEWEST 2026/2027 ACTUAL EXAM 80 QUESTIONS AND CORRECT (VERIFIED ANSWERS) COVERING RECEN

This document is a comprehensive resource for students preparing for the NR565 Week 5 exam on Diabetes Mellitus (DM) and Thyroid medications for the academic year 2026/2027. It includes 80 verified questions and answers, providing students with the most recent and frequently tested questions, ensuring a thorough understanding of the exam topics. The content covers a range of medications and their mechanisms, contraindications, and specific scenarios for their use, such as sulfonylureas, metformin, DPP-4 inhibitors, and thiazolidinediones.

Key insights include the primary mechanism of action of metformin, which decreases hepatic glucose production, and the correct management of hypoglycemia using the "15-15 rule." The document also explores the role of different types of insulin, highlighting rapid-acting insulin like Lispro for post-meal glucose control and long-acting insulins for maintaining 24-hour glucose control.

In addition to diabetes medications, the document addresses thyroid conditions, specifically the management of hyperthyroidism and the appropriate treatment for pregnant women with Graves' disease, emphasizing the use of Methimazole. It also discusses the advantages and disadvantages of Methimazole compared to PTU, such as its dosing schedule and onset of action.

This exam guide is a valuable tool for students seeking to excel in their pharmacology exams, focusing on diabetes and thyroid medications. It provides a clear understanding of the therapeutic approaches, potential side effects, and patient-specific considerations necessary for effective medication management.